title: Impact of acid-suppressive therapy on virologic response to atazanavir-based regimens in antiretroviral-experienced patients: a case series.
authors.forename: Tony
authors.initials: T
authors.lastname: Antoniou
authors.forename: Deborah
authors.initials: D
authors.lastname: Yoong
authors.forename: Lizanne
authors.initials: L
authors.lastname: Beique
authors.forename: Steve
authors.initials: S
authors.lastname: Chirhin
authors.forename: Anita
authors.initials: A
authors.lastname: Rachlis
authors.forename: Kevin
authors.initials: K
authors.lastname: Gough
authors.forename: Mona R
authors.initials: MR
authors.lastname: Loutfy
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D000863:Antacids / Q000627:therapeutic use*; D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D000069446:Atazanavir Sulfate; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009842:Oligopeptides / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D012189:Retrospective Studies
chemical_list: D000863:Antacids; D044966:Anti-Retroviral Agents; D009842:Oligopeptides; D011725:Pyridines; D000069446:Atazanavir Sulfate